Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2010
06/09/2010CN101721433A Double-mushroom polysaccharide preparation containing flammulina velutipes polysaccharide and lentinan polysaccharide and preparation method and application thereof
06/09/2010CN101721427A Method for preparing gallinaceous Newcastle disease transspecific factor
06/09/2010CN101721362A Antibody-containing solution pharmaceuticals
06/09/2010CN101269219B Method for preparing oligose absorbent charcoal carrier sustained-release agent
06/09/2010CN101224231B Method of extracting immunologic adjuvant component from cochinchina momordica seed
06/09/2010CN101194923B Novel medicament for treating systematic lupus erythematosus
06/09/2010CN101129823B Orally taken traditional Chinese medicine composition for treating anaphylactoid purpura
06/09/2010CN101104054B Method for preparing oral liquid for treating digestive system disease
06/09/2010CN101010076B Immune function-improving agent
06/09/2010CN100998405B Health-care food used for regulating immunocompetence of human
06/08/2010US7732588 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue
06/08/2010US7732583 efficient synthetic methods for economically mass producing glycolipids having an immunosuppressive action useful for the treatment of autoimmune diseases; 1,3-O-benzylidene-D-arabino-1,2,3,4-octanetetraol
06/08/2010US7732442 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
06/08/2010US7732437 Such as 3-[2-[4-(11,12-dihydro-6H-benzimidazo[2,1-b][3]benzazepin-6-yl)-2-(phenyl-methyl)-1-piperidinyl]ethyl]-2,10-dimethyl pyrimido[1,2- alpha ]benzimidazol-4(10H)-one
06/08/2010US7732407 Method for treatment of demyelinating central nervous system disease
06/08/2010US7732149 Methods of screening agonistic antibodies
06/08/2010US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor
06/08/2010US7731973 Administering estriol to treat multiple sclerosis, autoimmune diseases, psoriasis, Sjogren's syndrome, encephalomyelitis; inflammatory bowel, Crohn's, Hashimoto's, or Addison's disease; diabetes, myasthenia gravis, lupus, rheumatoid arthritis, polymyositis; immunotherapy; magnetic resonance imaging
06/08/2010US7731958 Adjust concentration of interleukins
06/08/2010US7731945 Immunotherapy for reversing immune suppression
06/08/2010CA2575902C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide
06/08/2010CA2440553C 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
06/08/2010CA2439241C Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
06/08/2010CA2434972C Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
06/08/2010CA2363991C Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor
06/08/2010CA2158047C Allergenic protein and peptides from house dust mite and uses therefor
06/03/2010WO2010062401A2 Treatment of osteolytic disorders and cancer using csf1r extracellular domain fusion molecules
06/03/2010WO2010062322A2 Modulation of the immune response
06/03/2010WO2010061971A1 Pyridine-3-carboxyamide derivative
06/03/2010WO2010061924A1 Avian influenza vaccine
06/03/2010WO2010061903A1 Pyrimidine derivative and pyridine derivative both having pi3k inhibitory activity
06/03/2010WO2010061877A1 Mineral absorption improver, and method for improving absorption of minerals
06/03/2010WO2010061180A1 Quinoline derivatives as p13 kinase inhibitors
06/03/2010WO2010060208A1 Peptide adjuvants
06/03/2010WO2010007165A3 Treatment of inflammatory diseases with mammal beta defensins
06/03/2010WO2009126688A8 Novel compositions and methods for the treatment of immune related diseases
06/03/2010WO2009052090A8 Silicate containing compositions and methods of treatment
06/03/2010US20100137605 Process for production of piperidine derivatives
06/03/2010US20100137412 Lentivirus pseudotyped with influenza hemagglutinin and methods of use
06/03/2010US20100137387 Beta-keto-amide derivatives useful as ion channel modulators
06/03/2010US20100137364 6-Aminoisoquinoline Compounds
06/03/2010US20100137351 Imidazoacridinone derivative compounds and methods for their use
06/03/2010US20100137345 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
06/03/2010US20100137319 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
06/03/2010US20100137308 Quinoxaline Compounds and Use Thereof
06/03/2010US20100137307 Novel 1,2,3,4,-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced terein and has glucocorticoid receptor-binding activity
06/03/2010US20100137275 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
06/03/2010US20100137268 Phthalazinone modulators of h1 receptors and/or ltc4 receptors
06/03/2010US20100137237 Process for the preparation of an (rp)-8-substituted camps
06/03/2010US20100137231 6"-amino-6"-deoxygalactosylceramides
06/03/2010US20100137208 Intratumorally administered lactoferrin in the treatment of malignantneoplasms and other hyperproliferative diseases
06/03/2010US20100137198 Pharmaceutical composition for topical application
06/03/2010US20100137196 Histone deacetylases, and uses related thereto
06/03/2010US20100137195 Production of Recombinant IL-18 Binding Protein
06/03/2010US20100136695 Double-stranded oligonucleotides
06/03/2010US20100136628 competing with natural OX40L for blocking OX40R-mediated cell signaling in the prophylaxis and/or treatment of diseases related to activated T cells
06/03/2010US20100136625 Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136108 Formulation for retinoid-containing soft gelatin capsules
06/03/2010US20100136093 Immunotherapeutic Method For Increasing Groundnut Tolerance In A Subject
06/03/2010US20100136092 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same
06/03/2010US20100136060 Methods of reducing porcine circovirus-associated disease outbreaks
06/03/2010US20100136057 Virulence of streptococci
06/03/2010US20100136056 Novel insertion sites in pox vectors
06/03/2010US20100136054 Flavivirus ns1 subunit vaccine
06/03/2010US20100136043 Composition comprising immunogenic microparticles
06/03/2010US20100136039 Borrelia antigens
06/03/2010US20100136036 Unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions
06/03/2010US20100136034 Novel multimeric molecules, a process for preparing the same and the use thereof for manufacturing medicinal drugs
06/03/2010US20100136032 Trimeric ox40-immunoglobulin fusion protein and methods of use
06/03/2010US20100136030 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases
06/03/2010US20100136020 Uses of il-174 antagonists for inhibiting a th2 immune response
06/03/2010US20100136018 Anti-FC-receptor single domain antibodies (nanobodies-tm) and therapeutic use
06/03/2010US20100136014 GIPs, a Family of Polypeptides with Transcription Factor Activity that Interact with Goodpasture Antigen Binding Protein
06/03/2010US20100136008 TACI-Fc Fusion Proteins, Methods of Making and Uses Thereof
06/03/2010US20100136006 Treatment of osteolytic disorders and cancer using csf1r extracellular domain fusion molecules
06/03/2010US20100136005 Method of Treatment Using Humanized Anti-CD11a Antibodies
06/03/2010US20100136003 Uses of mammalian cytokine; related reagents
06/03/2010US20100136002 Methods for treating and preventing multiple sclerosis
06/03/2010US20100136000 Treatment of follicular lymphomas using inhibitors of the lt pathway
06/03/2010US20100135997 Polypeptide monomers and dimers containing mutated ilt
06/03/2010US20100135981 Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases
06/03/2010US20100135980 Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging, disorders of aging, cancer, as growth factors, and as an alternative to stem cell therapy
06/03/2010US20100135975 CD133 Epitopes
06/03/2010US20100135974 Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory disease
06/03/2010US20100135962 Novel Bacteriophage and Antibacterial Composition Comprising the Same
06/03/2010US20100135959 Human Interferon Molecules and Their Uses
06/03/2010US20100135958 Method for treating cancer in humans
06/03/2010US20100135948 Anti-Autoimmune Antibodies for Treatment of Pemphigus
06/03/2010US20100135910 Modulation of Anergy and Methods for Isolating Anergy-Modulating Compounds
06/03/2010CA2745004A1 Pyridine-3-carboxyamide derivative
06/03/2010CA2740566A1 Peptide adjuvants
06/02/2010EP2192190A1 Yogurt containing pectin hydrolysis products
06/02/2010EP2192179A1 Cdh3 peptide and medicinal agent comprising the same
06/02/2010EP2192131A1 Immunoglobulins devoid of light chains
06/02/2010EP2190880A1 Cytotoxicity mediation of cells evidencing surface expression of cd9
06/02/2010EP2190849A2 Compounds useful as protein kinases inhibitors
06/02/2010EP2190826A2 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
06/02/2010EP2190464A2 Use of leptin(22-56) as a therapeutic agent
06/02/2010EP2190463A2 Use of thymopentin as a therapeutic agent
1 ... 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 ... 1172